UNSPSC 41151613: Beta or gamma counter for clinical use

In this classification a beta or gamma counter for clinical use is a device intended to detect and count beta or gamma radiation emitted by clinical samples. Clinical samples are prepared by addition of a radioactive reagent to the sample. These measurements are useful in the diagnosis and treatment of various disorders US FDA regulates Beta or gamma counter for clinical use under 21 CFR 862.2320 and under FDA product code JJJ.

UNSPSC 41151613 Beta or gamma counter for clinical use, a Commodity code, does not align with state and local government procurement activity in the recent opportunities block. The opportunities posted under this code span laboratory and clinical instrumentation—including gas chromatographs, liquid chromatography-mass spectrometers, rheometers, motion-capture systems, and wind-tunnel equipment—none of which are beta or gamma counters. The code shows little relevant recent activity; the mismatch suggests either miscoding by issuing bodies or that beta and gamma counters operate outside the volume of state and local purchasing tracked here.

The recent opportunities block contains no solicitations explicitly requesting beta or gamma counters. State and local buyers in Mississippi, Texas, Oregon, Florida, Michigan, and Wisconsin are acquiring specialized analytical and research equipment through sole-source and competitive procurements, but the work being purchased does not include radiation detection or counting instruments. A business development professional evaluating this code should verify that their product or service truly corresponds to UNSPSC 41151613 before committing pursuit resources.